Lasa Supergenerics
LASA · Pharma > Pharmaceuticals & Drugs · Chairman: Omkar Herlekar · MD: Omkar Herlekar · Listing date: Sept. 22, 2017 · Employees: 194 · Mumbai · http://lasalabs.com

Stock Price vs Company Growth
1d
1.9%
1w
2.6%
1m
3.4%
3m
0.3%
6m
38.1%
1y
40.1%
5y
37.4%
all
28.6%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 7.49 1.9%
7.01
8.99
Company Overview

Sales
25.3 Cr
Growth: -25.7%
Profit after Tax
-34.1 Cr
Growth: -22.9%
Micro Cap
37.5 Cr
P/S: 1.4x
Industry P/S: 2.7x
Fundamentals

Sales (Cr) ₹ 25.3
Growth -25.7%
EBITDA N/A
P/S 1.4x
Dividend 0.0%
P/E -1.1x
Book Value ₹ 8.11
PEG Ratio 0.0x
ROE -73.2%
P/B 0.9x
Shareholding Pattern

Institutions
Promoters
Omkar Pravin Herlekar
64.47 %
Others
Bebi Dharma Padhir
2.82 %
Anil Vishanji Dedhia
1.76 %
Increase    Decrease    No change
Company Profile Detailed

The company is specialises in ‘catalyst chemistry’ and manufactures anthelmintic/ veterinary API products with the largest production capabilities and product categories in IndiaProduct CategoriesVeterinary API ProductsOther API ProductsAnimal Feed IngredientsReagents For Therapeutic Use
Investors (19)
Followers (3)